Reuters logo
BRIEF-Pharma Mar starts clinical studies with new compound PM14 in patients with solid tumors
September 19, 2017 / 2:36 PM / 3 months ago

BRIEF-Pharma Mar starts clinical studies with new compound PM14 in patients with solid tumors

Sept 19 (Reuters) - PHARMA MAR SA:

* SAYS STARTS CLINICAL STUDIES WITH NEW COMPOUND PM14 IN PATIENTS WITH SOLID TUMORS Source text for Eikon:

Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below